Comparing migraine prevention drugs: atogepant, propranolol, topiramate
Treatments studied
Part of Brain & nervous system clinical trials.
This study compares three common migraine prevention medications to see which works best. You might be able to join if you have migraines at least 4 days a month and haven't taken these specific drugs before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have had migraines for at least 12 months, starting before age 50.
- You have at least 4 moderate to severe headache days per month (confirmed by a headache diary).
- You have not taken atogepant, propranolol, or topiramate before (or are willing to stop them).
- You are not pregnant or breastfeeding, and agree to use birth control if needed.
- You do not have certain rare migraine types (like hemiplegic migraine) or epilepsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two first-line migraine prevention medications in primary care. It's designed for adults who have frequent migraines (4 to 14 days per month) and have not yet tried a preventive medication.
This study tests if atogepant, a daily pill, can prevent migraines in adults. It is for people whose doctor has already decided to prescribe atogepant for migraine prevention.
This trial tests whether a computer algorithm can help pick the best migraine prevention medicine for you. You'll try one of several common preventives and track your headaches.
This study tests a once-daily pill, atogepant, to see if it safely prevents chronic or episodic migraines in Korean adults. It's meant for people whose doctor has already prescribed the pill for migraine prevention.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.